The Adherence to Oral Anticoagulant in Chinese Patients With NVAF

NCT04942873 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2021-06-29

No results posted yet for this study

Summary

Investigate the compliance of oral anticoagulants in Chinese NVAF patients and find out the causes, so as to provide basis for formulating effective measures to improve the compliance of oral anticoagulants.

Conditions

  • Nonvalvular Atrial Fibrillation

Interventions

OTHER

adherence

PDC value and MMAS-8 scale were used to evaluate the compliance of patients with dabigatran, rivaroxaban and wafarin

Sponsors & Collaborators

  • Second Affiliated Hospital, School of Medicine, Zhejiang University

    lead OTHER

Principal Investigators

  • huang yuwen, master · The Second Affiliated Hospital of Medical College of Zhejiang University

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-20
Primary Completion
2022-06-06
Completion
2023-06-10

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04942873 on ClinicalTrials.gov